These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 6866393)

  • 21. [Clinical application of Fc-rosette. 1. Inhibition of Fc-rosette formation by systemic lupus erythematosus sera. A method for detection of circulating immune complexes].
    Moyito T; Aotsuka S; Yokohari R; Moroi Y; Yokohari R
    Ryumachi; 1976 Mar; 16(1):4-11. PubMed ID: 1085992
    [No Abstract]   [Full Text] [Related]  

  • 22. [Circulating immune complexes (PEG tests) in systemic lupus erythematosus].
    Ivanova MM; Nasonov EL; Solov'ev SK; Speranskiĭ AI; Sura VV
    Ter Arkh; 1982; 54(6):63-8. PubMed ID: 7112424
    [No Abstract]   [Full Text] [Related]  

  • 23. Immune complex systems in the nephritis of systemic lupus erythematosus.
    Agnello V; Koffler D; Kunkel HG
    Kidney Int; 1973 Feb; 3(2):90-9. PubMed ID: 4121101
    [No Abstract]   [Full Text] [Related]  

  • 24. [Studies on the correlation between the size of circulating immune complexes and glomerular histology in lupus nephritis].
    Yoshida M; Kimura T; Nagasawa T
    Nihon Jinzo Gakkai Shi; 1982 Aug; 24(8):893-900. PubMed ID: 7176185
    [No Abstract]   [Full Text] [Related]  

  • 25. Circulating immune complex assays and systemic lupus erythematosus.
    Cairns SA
    Contrib Nephrol; 1983; 35():7-34. PubMed ID: 6339163
    [No Abstract]   [Full Text] [Related]  

  • 26. [Circulating immune complexes and C3 in patients with systemic lupus erythematosus. The relationship between clinical manifestations and nephropathy (author's transl)].
    Rodríguez-Valverde V; Peña Sagredo JL; Orte Martínez J; Novo Fernández MJ; Sánchez Andrada S; Sampedro Alvarez J
    Med Clin (Barc); 1982 May; 78(9):353-7. PubMed ID: 6808263
    [No Abstract]   [Full Text] [Related]  

  • 27. [Circulating immune complexes in rheumatic diseases].
    Nasonov EL; Sura VV; Borisov IA; Timofeeva EB
    Ter Arkh; 1981; 53(12):118-27. PubMed ID: 7336334
    [No Abstract]   [Full Text] [Related]  

  • 28. Different mode of circulating immune complexes and anti-ssDNA antibodies in sera of lepromatous leprosy and systemic lupus erythematosus.
    Furukawa F; Yoshida H; Sekita K; Ozaki M; Imamura S; Hamashima Y
    Lepr Rev; 1984 Sep; 55(3):291-9. PubMed ID: 6492990
    [No Abstract]   [Full Text] [Related]  

  • 29. [Immunological and biochemical characteristics of circulating immune complexes in rheumatoid arthritis and systemic lupus erythematosus].
    Venalis AI; Matulis AA; Mishkinite GA; Stankaĭtene DI
    Ter Arkh; 1983; 55(7):24-8. PubMed ID: 6194570
    [No Abstract]   [Full Text] [Related]  

  • 30. Circulating DNA-containing immune complexes in SLE.
    Steinman CR
    J Immunol; 1983 Apr; 130(4):1990-1. PubMed ID: 6833757
    [No Abstract]   [Full Text] [Related]  

  • 31. Study of circulating immune complex size in systemic lupus erythematosus.
    Tung KS; DeHoratius RJ; Williams RC
    Clin Exp Immunol; 1981 Mar; 43(3):615-25. PubMed ID: 7285395
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Origin of DNA from DNA/anti-DNA antibody immune complexes in systemic lupus erythematosus patients.
    Guéttari N; Lucotte G
    Autoimmunity; 1988; 1(1):77-8. PubMed ID: 2979608
    [No Abstract]   [Full Text] [Related]  

  • 33. [Characterization of immune complexes precipitated by polyethylene glycols in systemic lupus erythematosus].
    Sáenz E; Hernández C; Recart S; Catalán R; Borzone L; Tapia P
    Rev Med Chil; 1985 Dec; 113(12):1165-9. PubMed ID: 3837302
    [No Abstract]   [Full Text] [Related]  

  • 34. Circulating immune complexes of IgG, IgA, and IgM classes in various glomerular diseases.
    Doi T; Kanatsu K; Sekita K; Yoshida H; Nagai H; Hamashima Y
    Nephron; 1982; 32(4):335-41. PubMed ID: 6762505
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Circulating immune complexes, immunoglobulins and phagocytic activity of neutrophils in the evaluation of the activity and effectiveness of treatment of systemic lupus erythematosus].
    Demin AA; Speranskiĭ AI; Sentiakova TN; Riazantseva TA; Poliachenko EA
    Ter Arkh; 1985; 57(8):52-7. PubMed ID: 4071435
    [No Abstract]   [Full Text] [Related]  

  • 36. [Studies on the importance of the fluorescence-antiglobulin test and the antiglobulin-consumption test for the demonstration of antinuclear serum factors].
    Mueller-Eckhardt C; Schmidt K; Becker W
    Blut; 1968 Jul; 17(4):227-37. PubMed ID: 4173999
    [No Abstract]   [Full Text] [Related]  

  • 37. Circulating immune complexes in systemic lupus erythematosus: a reappraisal of the solid phase C1q radioimmunoassay.
    Woodroffe AJ; Nozza JM; Muller KD; McIntosh SL; Hale GM; Clarkson AR
    J Clin Lab Immunol; 1988 May; 26(1):5-7. PubMed ID: 3263507
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Immunopathogenetic aspects of allergy to drugs].
    Patriarca G
    Recenti Prog Med; 1978 Nov; 65(5):391-420. PubMed ID: 153567
    [No Abstract]   [Full Text] [Related]  

  • 39. [Detection of DNA anti-DNA immune complexes in systemic lupus erythematosus sera (author's transl)].
    Sarai T; Sakamoto K; Miyawaki S; Ofuji T
    Ryumachi; 1982 Feb; 22(1):20-7. PubMed ID: 7089743
    [No Abstract]   [Full Text] [Related]  

  • 40. Circulating C1q binding immune complexes in relatives of patients with systemic lupus erythematosus.
    Elkon KB; Walport MJ; Rynes RI; Black CM; Batchelor JR; Hughes GR
    Arthritis Rheum; 1983 Jul; 26(7):921-4. PubMed ID: 6603223
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.